DOI QR코드

DOI QR Code

High Risk Human Papilloma Virus Genotypes in Kurdistan Region in Patients with Vaginal Discharge

  • Hussein, Nawfal R (Department of Internal Medicine, Faculty of Medical Science, School of Medicine, University of Duhok) ;
  • Balatay, Amer A (Department of Pathology, Faculty of Medical Science, School of Medicine, University of Duhok) ;
  • Assafi, Mahde S (Department of Biology, Faculty of Sciences, University of Zakho) ;
  • Al-Mufty, Tamara Abdulezel (Department of Pathology, Maternity Teaching Hospital) ;
  • Khalil, Amira S (Gynecology Hospital)
  • Published : 2016.07.01

Abstract

Background: The human papilloma virus (HPV) is considered as the major risk factor for the development of cervical cancer. This virus is of different genotypes and generally can be classified into high and low risk types. Objective: To determine the rate of high risk HPV genotypes in women with vaginal discharge and lower abdominal pain in Kurdistan region, Iraq. Materials and Methods: Cervical swabs were taken from 104 women. DNA was extracted and the polymerase chain reaction (PCR) technique was used to determine the presence of high risk genotypes. Results: It was found that 13/104 (12.5%) of the samples were positive for high risk HPV genotypes. Amongst those who were positive, 4/13 (30.7%) were typed as genotype 16 and 7/13 (53.8%) showed mixed genotyping. On the other hand, genotypes 53 and 56 were found in only one sample each. Conclusions: High risk HPV genotypes are not uncommon and further community based study is needed to determine the prevalence of HPV and its genotypes and plan for prevention of infection.

Keywords

HPV;high risk group prevalence;vaginal discharge;cervical cancer;Iraq;Kurdistan Region

References

  1. Alhamany Z, El Mzibri M, Kharbach A, et al. (2010). Prevalence of human papillomavirus genotype among Moroccan women during a local screening program. J Infect Dev Ctries, 4, 732-39.
  2. Ali KS, Jubrael JMS, Ali HYM (2012). AOS4 Detection of human papillomavirus DNA in patients with different cervical lesions in Kurdistan region, Iraq. European J Cancer, 48, 4-5.
  3. AlObaid A, Al-Badawi IA, Al-Kadri H, et al. (2014). Human papillomavirus prevalence and type distribution among women attending routine gynecological examinations in Saudi Arabia. BMC Infectious Diseases, 14, 1-8. https://doi.org/10.1186/1471-2334-14-1
  4. Ault KA (2006). Epidemiology and natural history of human papillomavirus infections in the female genital tract. Infectious Diseases Obstetrics Gynecol, 2006, 40470.
  5. Bondagji NS, Gazzaz FS, Sait K, et al. (2013). Prevalence of high-risk human papillomavirus infections in healthy Saudi women attending gynecologic clinics in the western region of Saudi Arabia. Ann Saudi Med, 33, 13-17. https://doi.org/10.5144/0256-4947.2013.13
  6. Cancer ICoESoC ( 2007). Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for573 women with cervical cancer and509 women without cervical cancer from 24 epidemiological studies. Lancet, 370, 1609-21. https://doi.org/10.1016/S0140-6736(07)61684-5
  7. Dursun P, Senger SS, Arslan H, et al. (2009). Human papillomavirus (HPV) prevalence and types among Turkish women at a gynecology outpatient unit. BMC Infectious Diseases, 9, 191-91. https://doi.org/10.1186/1471-2334-9-191
  8. Farjadian S, Asadi E, Doroudchi M, et al. (2003). High risk HPV types in southern Iranian patients with cervical cancer. Pathol Oncol Res, 9, 121-25. https://doi.org/10.1007/BF03033756
  9. Franco EL, Villa LL, Sobrinho JoP, et al. (1999). Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infectious Diseases, 180, 1415-23. https://doi.org/10.1086/315086
  10. Giuliano AR, Harris R, Sedjo RL, et al. (2002). Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study. J Infectious Diseases, 186, 462-69. https://doi.org/10.1086/341782
  11. GLOBOCAN. 2012. Cervix utri [Online]. Available: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.
  12. Kuhn L, Denny L, Pollack A, et al. (2000). Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. J Natl Cancer Inst, 92, 818-25. https://doi.org/10.1093/jnci/92.10.818
  13. Obeidat B, Matalka I, Mohtaseb A, et al. (2013). Prevalence and distribution of high-risk human papillomavirus genotypes in cervical carcinoma, low-grade, and high-grade squamous intraepithelial lesions in Jordanian women. Eur J Gynaecol Oncol, 34, 257-60.
  14. Sawaya GF, Kulasingam S, Denberg TD, et al. (2015). Cervical cancer screening in average-risk women: best practice advice from the Clinical Guidelines Committee of the American College of Physicians Cervical Cancer Screening in Average-Risk Women. Ann Internal Med, 162, 851-59. https://doi.org/10.7326/M14-2426
  15. Smith JS, Bosetti C, Munoz N, et al. (2004). Chlamydia trachomatis and invasive cervical cancer: A pooled analysis of the IARC multicentric case-control study. Int J Cancer, 111, 431-39. https://doi.org/10.1002/ijc.20257
  16. Woodman CBJ, Collins SI, Young LS (2007). The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer, 7, 11-22. https://doi.org/10.1038/nrc2050
  17. Youssef MA, Abdelsalam L, Harfoush RA, et al. (2016). Prevalence of human papilloma virus (HPV) and its genotypes in cervical specimens of Egyptian women by linear array HPV genotyping test. Infect Agent Cancer, 11, 6. https://doi.org/10.1186/s13027-016-0053-1